FIELD: medicine.
SUBSTANCE: what is described is a histo-equivalent bioplastic material comprising a carrier in the form of a matrix that is presented by a native form of hyaluronic acid. The histo-equivalent bioplastic material is prepared by mixing 1.5% hyaluronic acid and 5% peptide complex in the following proportions: 80-90 ml and 10-20 ml, respectively to form a viscous elastic gel that is placed on a mould carrier and exposed to ultraviolet photopolymerisation in a laminar flow hood for 5-7 hours, and then transferred onto a perforation apparatus with the finished material being perforated and notched.
EFFECT: more effective wound healing.
1 tbl, 11 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
REGENERATIVE BIOPLASTY TECHNIQUE FOR INVESTING TISSUE DEFECTS | 2013 |
|
RU2547386C1 |
METHOD OF RECOVERY OF DEFECTS OF COVERING TISSUES | 2016 |
|
RU2644306C1 |
COSMETIC SKIN | 2013 |
|
RU2528899C1 |
NANOSTRUCTURED BIOPLASTIC MATERIAL | 2010 |
|
RU2425694C1 |
MICRO-NANOSTRUCTURED BIOPLASTIC MATERIAL | 2012 |
|
RU2481127C1 |
METHOD OF TREATING DEFECTS OF SKIN AND SOFT TISSUES IN PATIENTS WITH DIABETES MELLITUS AND METHOD OF INTRODUCTION OF DRUG THEREFOR | 2017 |
|
RU2679449C1 |
BIOPLASTIC MATERIAL | 2008 |
|
RU2367476C1 |
ORGAN-SPECIFIC BIOPLASTIC MATERIAL BASED ON SOLUBLE FORM OF STABILIZED EXTRACELLULAR MATRIX | 2019 |
|
RU2722744C1 |
METHOD FOR SOFT TISSUES DEFECTS TREATMENT IN PATIENTS WITH DIABETIC FOOT SYNDROME | 2016 |
|
RU2619257C1 |
3D BIOPLASTIC MATERIAL BASED ON HYDROCOLLOID OF HYALURONIC ACID | 2013 |
|
RU2565398C2 |
Authors
Dates
2014-04-20—Published
2013-02-21—Filed